The science behind preparing and responding to pandemic influenza: The lessons and limits of science

Clinical Infectious Diseases

Volumn 52, Issue SUPPL. 1, 2011, Pages

  Schuchat, Anne ^a   Bell, Beth P ^a   Redd, Stephen C ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE; OSELTAMIVIR; PERAMIVIR;

ARTICLE; DECISION MAKING; DISEASE SEVERITY; GENE SEQUENCE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; IMMUNE RESPONSE; INFLUENZA A (H1N1); MORBIDITY; MORTALITY; PANDEMIC INFLUENZA; PRIORITY JOURNAL; RISK FACTOR; SEASONAL INFLUENZA; SINGLE DRUG DOSE; SURGICAL MASK; VENTILATOR; VIRUS SHEDDING; VIRUS TRANSMISSION;

BIOMEDICAL RESEARCH; CIVIL DEFENSE; COMMUNICABLE DISEASE CONTROL; HUMANS; INFLUENZA, HUMAN; PANDEMICS;

EID: 79953732563     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciq007     Document Type: Article

References (33)

1. US Homeland Security Council. National strategy for pandemic in-fluenza. Washington, DC: U.S. Homeland Security Council, 2005. Available at: http://permanent.access.gpo.gov/lps64971/nspi.pdf. Accessed 23 February 2010.
2. US Department of Health and Human Services. HHS pandemic in-fluenza plan. Washington, DC: U.S. Department of Health and Human Services; 2005. Available at: http://www.hhs.gov/pandemicflu/plan/pdf/HHSPandemicInfluenzaPlan.pdf. Accessed 23 February 2010.
3. US Department of Health and Human Services. HHS pandemic planning update, a report from Secretary Michael O. Leavitt. Wash-ington, DC: US Department of Health and Human Services, 2006. Available at: http://www.flu.gov/professional/ pdf/panflu20060313.pdf Accessed 23 February 2010.
4. United States Government Accountability Office. Influenza pandemic: sustaining focus on the nation's planning and preparedness. Washington, DC: Government Accountability Office 2009. Report No.: GAO-09-334.
5. Centers for Disease Control and Prevention. Swine influenza A (H1N1) infection in two children-Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 2009; 58(15):400-402.
6. Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vac-cine. N Engl J Med 2006; 354(13):1343-1351.
7. Stephenson I, Nicholson KG, Hoschler K, et al. Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1. N Engl J Med 2008; 359(15):1631-1633.
8. Zhu FC, Wang H, Fang HH, et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 2009; 361(25):2414-2423.
9. Greenberg ME, Lai MH, Hartel GF, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009; 361(25): 2405-2413.
10. Clark TW, Pareek M, Hoschler K, et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med 2009; 361(25):2424-2435.
11. Keystone Center for Science and Public Policy. Citizen voices on pandemic flu choices: A report of the public engagement project on pandemic influenza. Department Health Hum Serv 2005. Available at: http://www.hhs.gov/nvpo/PEPPPI/ PEPPPICompleteFinalReport.pdf Accessed 17 March 2010.
12. Centers for Disease Control and Prevention (CDC). Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Re-comm Rep 2009; 58(RR-10):1-8.
13. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic charac-teristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325(5937):197-201.
14. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361(20):1935-1944.
15. Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374(9688):451-458.
16. Louie JK, Acosta M, Jamieson DJ, Honein MA. California Pandemic (H1N1) Working Group. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2010; 362(1):27-35.
17. Dominguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically ill pa-tients with 2009 influenza A(H1N1) in Mexico. JAMA 2009; 302(17): 1880-1887.
18. Centers for Disease Control and Prevention. Evaluation of rapid influenza diagnostic tests for detection ofnovel influenza A (H1N1) Virus-United States, 2009. MMWR Morb Mortal Wkly Rep 2009; 58(30):826-829.
19. White LF, Wallinga J, Finelli L, et al. Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza Other Resp Viruses 2009; 3(6):267-276.
20. Centers for Disease Control and Prevention. Serum cross-reactive an-tibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009; 58(19):521-524.
21. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361(20):1945-1952.
22. Centers for Disease Control and Prevention (CDC). Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1)-United States, May-June 2009. MMWR Morb Mortal Wkly Rep 2009; 58(44):1241-1245.
23. Garcia-Garcia L, Valdespino-Gomez JL, Lazcano-Ponce E, et al. Partial protection of seasonal trivalent inactivated vaccine against novel pan-demic influenza A/H1N1 2009: case-control study in Mexico City. BMJ 2009; 339:b3928.
24. Centers for Disease Control and Prevention. Update: influenza activity-United States, August 30, 2009-January 9, 2010. MMWR Morb Mortal Wkly Rep 2010; 59(2):38-43.
25. Reed C, Angulo FJ, Swerdlow DL, et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis 2009; 15(12):2004-2007.
26. Uyeki T. Antiviral treatment for patients hospitalized with 2009 pan-demic influenza A (H1N1). N Engl J Med 2009; 361(23):e110.
27. U.S. Federal Immunization Safety Task Force. Federal plans to monitor immunization safety for the pandemic 2009-H1N1 Influenza Vacci-nation Program 2009. Washington, D.C.: U.S. Department of Health and Human Services. Available at: http://ww.flu.gov/professional/fed-eral/fedplantomonh1n1immsafety.pdf. Accessed 23 February 2010.
28. Centersfor Disease Control and Prevention. Safetyofinfluenza A (H1N1) 2009 monovalent vaccines-United States, October 1-November 24, 2009. MMWR Early Release 2009. 58(December 4 2009):1-6.
29. Centers for Disease Control and Prevention. Interim results: influenza A (H1N1) 2009monovalentvaccinationcoverage-United States, October-December, 2010. MMWR Morb Mortal Wkly Rep 2010; 59(2):44-48.
30. Luby SP, Agboatwalla M, Feikin DR, et al. Effect of handwashing on child health: a randomised controlled trial. Lancet 2005; 366(9481):225-233. (Pubitemid 40981050)
31. Shine KI, Rogers B, Goldfrank LR. Novel H1N1 influenza and re-spiratory protection for health care workers. N Engl J Med 2009; 361(19):1823-1825.
32. Cauchemez S, Donnelley CA, Reed C, et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. NEJM 2009; 361:2619-2627.
33. Lessler J, Reich NG, Cummings DA, et al. Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. NEJM 2009; 261:2628-2636.